|
1
|
Tripathi KD: Essentials of medical
pharmacology. (7th edition). J.P. Medical Ltd. 2013.
|
|
2
|
Masui K, Gini B, Wykosky J, Zanca C,
Mischel PS, Furnari FB and Cavenee WK: A tale of two approaches:
Complementary mechanisms of cytotoxic and targeted therapy
resistance may inform next-generation cancer treatments.
Carcinogenesis. 34:725–738. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Patterson SL, Colbert Maresso K and Hawk
E: Cancer chemoprevention: Successes and failures. Clin Chem.
59:94–101. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dedeurwaerder S, Defrance M, Calonne E,
Denis H, Sotiriou C and Fuks F: Evaluation of the infinium
methylation 450 K technology. Epigenomics. 3:771–784. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Theodoratou E, Timofeeva M, Li X, Meng X
and Ioannidis JPA: Nature, nurture, and cancer risks: Genetic and
nutritional contributions to cancer. Annu Rev Nutr. 37:293–320.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sauter ER: Breast cancer prevention:
Current approaches and future directions. Eur J Breast Health.
14:64–71. 2018.PubMed/NCBI
|
|
7
|
de Melo FHM, Oliveira JS, Sartorelli VOB
and Montor WR: Cancer chemoprevention: Classic and epigenetic
mechanisms inhibiting tumorigenesis. What have we learned so far?
Front Oncol. 8:6442018.PubMed/NCBI
|
|
8
|
Ko JH, Sethi G, Um JY, Shanmugam MK,
Arfuso F, Kumar AP, Bishayee A and Ahn KS: The role of resveratrol
in cancer therapy. Int J Mol Sci. 18:25892017. View Article : Google Scholar
|
|
9
|
Sur S and Panda CK: Molecular aspects of
cancer chemopreventive and therapeutic efficacies of tea and tea
polyphenols. Nutrition. 43-44:8–15. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu S, Zhu W, Thompson P and Hannun YA:
Evaluating intrinsic and non-intrinsic cancer risk factors. Nat
Commun. 9:34902018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Willett WC: Diet, nutrition, and avoidable
cancer. Environ Health Perspect. 103 Suppl:8 (Suppl 8):S165–S170.
1995. View Article : Google Scholar
|
|
12
|
Hussain A and Raina R: Flavones combat
cancer via multidimensional molecular approaches. Phytocompounds:
Sources and Bioactivities. Studium Press; 2019
|
|
13
|
Costea T, Hudiță A, Ciolac OA, Gălățeanu
B, Ginghină O, Costache M, Ganea C and Mocanu MM: Chemoprevention
of colorectal cancer by dietary compounds. Int J Mol Sci.
19:37872018. View Article : Google Scholar
|
|
14
|
Koosha S, Alshawsh MA, Looi CY, Seyedan A
and Mohamed Z: An association map on the effect of flavonoids on
the signaling pathways in colorectal cancer. Int J Med Sci.
13:374–385. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Maru GB, Hudlikar RR, Kumar G, Gandhi K
and Mahimkar MB: Understanding the molecular mechanisms of cancer
prevention by dietary phytochemicals: From experimental models to
clinical trials. World J Biol Chem. 7:88–99. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Attoub S, Hassan AH, Vanhoecke B, Iratni
R, Takahashi T, Gaben AM, Bracke M, Awad S, John A, Kamalboor HA,
et al: Inhibition of cell survival, invasion, tumor growth and
histone deacetylase activity by the dietary flavonoid luteolin in
human epithelioid cancer cells. Eur J Pharmacol. 651:18–25. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ham S, Kim KH, Kwon TH, Bak Y, Lee DH,
Song YS, Park SH, Park YS, Kim MS, Kang JW, et al: Luteolin induces
intrinsic apoptosis via inhibition of E6/E7 oncogenes and
activation of extrinsic and intrinsic signaling pathways in
HPV-18-associated cells. Oncol Rep. 31:2683–2691. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Meng G, Chai K, Li X, Zhu Y and Huang W:
Luteolin exerts pro-apoptotic effect and anti-migration effects on
A549 lung adenocarcinoma cells through the activation of MEK/ERK
signaling pathway. Chem Biol Interact. 257:26–34. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Abotaleb M, Samuel SM, Varghese E,
Varghese S, Kubatka P, Liskova A and Büsselberg D: Flavonoids in
cancer and apoptosis. Cancers (Basel). 11:282019. View Article : Google Scholar
|
|
20
|
Kedhari Sundaram M, Raina R, Afroze N,
Bajbouj K, Hamad M, Haque S and Hussain A: Quercetin modulates
signaling pathways and induces apoptosis in cervical cancer cells.
Biosci Rep. 39:BSR201907202019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Badgujar NV, Mistry KN, Rank DN and Joshi
CG: Screening of antiproliferative activity mediated through
apoptosis pathway in human non-small lung cancer A-549 cells by
active compounds present in medicinal plants. Asian Pac J Trop Med.
11:666–675. 2018. View Article : Google Scholar
|
|
22
|
Tuorkey MJ: Molecular targets of luteolin
in cancer. Eur J Cancer Prev. 25:65–76. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang SW, Chen YR, Chow JM, Chien MH, Yang
SF, Wen YC, Lee WJ and Tseng TH: Stimulation of Fas/FasL-mediated
apoptosis by luteolin through enhancement of histone H3 acetylation
and c-Jun activation in HL-60 leukemia cells. Mol Carcinog.
57:866–877. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen P, Zhang JY, Sha BB, Ma YE, Hu T, Ma
YC, Sun H, Shi JX, Dong ZM and Li P: Luteolin inhibits cell
proliferation and induces cell apoptosis via down-regulation of
mitochondrial membrane potential in esophageal carcinoma cells EC1
and KYSE450. Oncotarget. 8:27471–27480. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Park SH, Ham S, Kwon TH, Kim MS, Lee DH,
Kang JW, Oh SR and Yoon DY: Luteolin induces cell cycle arrest and
apoptosis through extrinsic and intrinsic signaling pathways in
MCF-7 breast cancer cells. J Environ Pathol Toxicol Oncol.
33:219–231. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mary V, Haris P, Varghese MK, Aparna P and
Sudarsanakumar C: Experimental probing and molecular dynamics
simulation of the molecular recognition of DNA duplexes by the
flavonoid luteolin. J Chem Inf Model. 57:2237–2249. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Imran M, Rauf A, Abu-Izneid T, Nadeem M,
Shariati MA, Khan IA, Imran A, Orhan IE, Rizwan M, Atif M, et al:
Luteolin, a flavonoid, as an anticancer agent: A review. Biomed
Pharmacother. 112:1086122019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Aggarwal R, Jha M, Shrivastava A and Jha
AK: Natural compounds: Role in reversal of epigenetic changes.
Biochemistry (Mosc). 80:972–989. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou Y, Zheng J, Li Y, Xu DP, Li S, Chen
YM and Li HB: Natural polyphenols for prevention and treatment of
cancer. Nutrients. 8:5152016. View Article : Google Scholar
|
|
30
|
Ruan J, Zhang L, Yan L, Liu Y, Yue Z, Chen
L, Wang AY, Chen W, Zheng S, Wang S and Lu Y: Inhibition of
hypoxia-induced epithelial mesenchymal transition by luteolin in
non-small cell lung cancer cells. Mol Med Rep. 6:232–238.
2012.PubMed/NCBI
|
|
31
|
Sundaram MK, Unni S, Somvanshi P, Bhardwaj
T, Mandal RK, Hussain A and Haque S: Genistein modulates signaling
pathways and targets several epigenetic markers in HeLa cells.
Genes (Basel). 10:9552019. View Article : Google Scholar
|
|
32
|
Masters JR: HeLa cells 50 years on: The
good, the bad and the ugly. Nat Rev Cancer. 2:315–319. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shariffa K: Apoptosis-journey of a cell in
life. Univ J Surg Surg Spec. 4(3)2018.
|
|
34
|
Li J, Han J, Hu Y and Yang J: Selection of
reference genes for quantitative real-time PCR during flower
development in tree peony (Paeonia suffruticosa Andr.).
Front Plant Sci. 7:5162016.PubMed/NCBI
|
|
35
|
Islam S, Islam N, Kermode T, Johnstone B,
Mukhtar H, Moskowitz RW, Goldberg VM, Malemud CJ and Haqqi TM:
Involvement of caspase-3 in epigallocatechin-3-gallate-mediated
apoptosis of human chondrosarcoma cells. Biochem Biophys Res
Commun. 270:793–797. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lennarz WJ and Lane MD: Encyclopedia of
biological chemistry. 2nd edition. Academic Press; 2013, PubMed/NCBI
|
|
37
|
Gul-e-Saba, Islamiah M, Ismail N, Mohamad
H, Sung YY and Muhammad TST: Induction of apoptosis by Aaptos sp.,
fractions in human breast cancer cell line, MCF-7. Int J Res Pharm
Sci. 9(2)2018.
|
|
38
|
Lee DH, Park KI, Park HS, Kang SR,
Nagappan A, Kim JA, Kim EH, Lee WS, Hah YS, Chung H, et al:
Flavonoids isolated from Korea Citrus aurantium L. induce G2/M
phase arrest and apoptosis in human gastric cancer AGS cells. Evid
Based Complement Alternat Med. 2012:5159012012.PubMed/NCBI
|
|
39
|
Abdal Dayem A, Choi HY, Yang GM, Kim K,
Saha SK and Cho SG: The anti-cancer effect of polyphenols against
breast cancer and cancer stem cells: Molecular mechanisms.
Nutrients. 8:5812016. View Article : Google Scholar
|
|
40
|
Mocanu MM, Nagy P and Szöllősi J:
Chemoprevention of breast cancer by dietary polyphenols. Molecules.
20:22578–22620. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Khan MA, Hussain A, Sundaram MK, Alalami
U, Gunasekera D, Ramesh L, Hamza A and Quraishi U:
(−)-Epigallocatechin-3-gallate reverses the expression of various
tumor-suppressor genes by inhibiting DNA methyltransferases and
histone deacetylases in human cervical cancer cells. Oncol Rep.
33:1976–1984. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hussain A, Mohsin J, Prabhu SA, Begum S,
Nusri Qel-A, Harish G, Javed E, Khan MA and Sharma C: Sulforaphane
inhibits growth of human breast cancer cells and augments the
therapeutic index of the chemotherapeutic Drug, gemcitabine. Asian
Pac J Cancer Prev. 14:5855–5860. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xue C, Chen Y, Hu DN, Iacob C, Lu C and
Huang Z: Chrysin induces cell apoptosis in human uveal melanoma
cells via intrinsic apoptosis. Oncol Lett. 12:4813–4820. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cao Z, Zhang H, Cai X, Fang W, Chai D, Wen
Y, Chen H, Chu F and Zhang Y: Luteolin promotes cell apoptosis by
inducing autophagy in hepatocellular carcinoma. Cell Physiol
Biochem. 43:1803–1812. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hu C, Cai X, Hu T, Lu W and Cao P:
Mechanism of growth inhibition effect of 3′, 4′, 5,
7-tetrahydroxyflavone on A549 cells. Zhongguo Zhong Yao Za Zhi.
37:1259–1264. 2012.(In Chinese). PubMed/NCBI
|
|
46
|
Aneknan P, Kukongviriyapan V, Prawan A,
Kongpetch S, Sripa B and Senggunprai L: Luteolin arrests cell
cycling, induces apoptosis and inhibits the JAK/STAT3 pathway in
human cholangiocarcinoma cells. Asian Pac J Cancer Prev.
15:5071–5076. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
George VC, Naveen Kumar DR, Suresh PK,
Kumar S and Kumar RA: Comparative studies to evaluate relative in
vitro potency of luteolin in inducing cell cycle arrest and
apoptosis in HaCaT and A375 cells. Asian Pac J Cancer Prev.
14:631–637. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
You Y, Wang R, Shao N, Zhi F and Yang Y:
Luteolin suppresses tumor proliferation through inducing apoptosis
and autophagy via MAPK activation in glioma. Onco Targets Ther.
12:23832019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lu X, Li Y, Li X and Aisa HA: Luteolin
induces apoptosis in vitro through suppressing the MAPK and PI3K
signaling pathways in gastric cancer. Oncol Lett. 14:1993–2000.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Samarghandian S, Nezhad MA and Mohammadi
G: Role of caspases, Bax and Bcl-2 in chrysin-induced apoptosis in
the A549 human lung adenocarcinoma epithelial cells. Anticancer
Agents Med Chem. 14:901–909. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Tu LY, Bai HH, Cai JY and Deng SP: The
mechanism of kaempferol induced apoptosis and inhibited
proliferation in human cervical cancer SiHa cell: From macro to
nano. Scanning. 38:644–653. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ren X, Zhang Z, Tian J, Wang H, Song G,
Guo Q, Tian J, Han Y, Liao Q, Liu G, et al: The downregulation of
c-Myc and its target gene hTERT is associated with the
antiproliferative effects of baicalin on HL-60 cells. Oncol Lett.
14:6833–6840. 2017.PubMed/NCBI
|
|
53
|
Huang L, Jin K and Lan H: Luteolin
inhibits cell cycle progression and induces apoptosis of breast
cancer cells through downregulation of human telomerase reverse
transcriptase. Oncol Lett. 17:3842–3850. 2019.PubMed/NCBI
|
|
54
|
Song KH, Woo SR, Chung JY, Lee HJ, Oh SJ,
Hong SO, Shim J, Kim YN, Rho SB, Hong SM, et al: REP1 inhibits
FOXO3-mediated apoptosis to promote cancer cell survival. Cell
Death Dis. 8:e25362018. View Article : Google Scholar
|
|
55
|
Zhang B, Gui LS, Zhao XL, Zhu LL and Li
QW: FOXO1 is a tumor suppressor in cervical cancer. Genet Mol Res.
14:6605–6616. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Zhang Y, Chen S, Wei C, Rankin GO, Ye X
and Chen YC: Flavonoids from Chinese bayberry leaves induced
apoptosis and G1 cell cycle arrest via Erk pathway in ovarian
cancer cells. Eur J Med Chem. 147:218–226. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Srivastava S, Somasagara RR, Hegde M,
Nishana M, Tadi SK, Srivastava M, Choudhary B and Raghavan SC:
Quercetin, a natural flavonoid interacts with DNA, arrests cell
cycle and causes tumor regression by activating mitochondrial
pathway of apoptosis. Sci Rep. 6:240492016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Fang X, Yu S, Eder A, Mao M, Bast RC Jr,
Boyd D and Mills GB: Regulation of BAD phosphorylation at serine
112 by the Ras-mitogen-activated protein kinase pathway. Oncogene.
18:6635–6640. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Khoo BY, Chua SL and Balaram P: Apoptotic
effects of chrysin in human cancer cell lines. Int J Mol Sci.
11:2188–2199. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Cardoso MFS, Castelletti CHM, Lima-Filho
JL, Martins DBG and Teixeira JAC: Putative biomarkers for cervical
cancer: SNVs, methylation and expression profiles. Mutat Res.
773:161–173. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Okkenhaug K, Bilancio A, Farjot G, Priddle
H, Sancho S, Peskett E, Pearce W, Meek SE, Salpekar A, Waterfield
MD, et al: Impaired B and T cell antigen receptor signaling in
p110delta PI 3-kinase mutant mice. Science. 297:1031–1034.
2002.PubMed/NCBI
|
|
62
|
Wang S, Zhang J, Chen M and Wang Y:
Delivering flavonoids into solid tumors using nanotechnologies.
Expert Opin Drug Deliv. 10:1411–1428. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Yuan ZP, Chen LJ, Fan LY, Tang MH, Yang
GL, Yang HS, Du XB, Wang GQ, Yao WX, Zhao QM, et al: Liposomal
quercetin efficiently suppresses growth of solid tumors in murine
models. Clin Cancer Res. 12:3193–3199. 2006. View Article : Google Scholar : PubMed/NCBI
|
